{
    "nct_id": "NCT06058650",
    "official_title": "Pilot Clinical Study to Evaluate Molecular Breast Imaging- Guidance for Sampling of Breast Abnormalities",
    "inclusion_criteria": "* PART I: Women aged 18 years or older\n* PART I: If able to become pregnant, negative pregnancy test within 48 hours prior to MBI biopsy procedure\n* PART I: Individuals who have previously (within the last 3 years) undergo an MBI study and were found to have at least one breast imaging finding on MBI that was subsequently shown (through additional imaging, biopsy or follow-up) to be benign in nature\n* PART I: Individuals who have agreed to participate in the study and who have signed the study-specific informed consent\n* PART II: Women aged 18 years or older\n* PART II: If able to become pregnant, negative pregnancy test within 48 hours prior to MBI biopsy procedure\n* PART II: Individuals who have previously (within the last 3 years) undergone an MBI study and were found to have at least one breast imaging finding on MBI that was subsequently shown (through additional imaging, biopsy or follow-up) to be benign or probably benign in nature\n* PART II: Individuals who had recent conventional imaging work-up including either x-ray mammography, ultrasound, MBI, or MRI of the breast and are found to have at least one breast imaging finding for which biopsy is required or recommended, specifically:\n\n  * Individuals who have a breast abnormality(ies) on imaging with mammography, ultrasound, MBI, or MRI (as per American College of Radiology [ACR] Breast Imaging Reporting and Data System [BIRADS] 3, or higher) and requiring imaging follow-up or biopsy confirmation\n* PART II: Individuals who have agreed to participate in the study and who have signed study-specific informed consent\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* PART I: Women who are pregnant\n* PART I: Women who are currently lactating or discontinued breastfeeding < 2 months prior to the study\n* PART I: Age less than 18 years\n* PART I: Women with breast implant(s) in the breast containing the lesion of interest\n* PART I: Inability to provide informed consent\n* PART II: Women who are pregnant\n* PART II: Women who are currently lactating or discontinued breastfeeding < 2 months prior to the study\n* PART II: Age less than 18 years\n* PART II: Women with breast implant(s) in the breast containing the lesion of interest\n* PART II: Women who have recently (within the last 3 months) undergone biopsy of the breast finding\n* PART II: Women who are scheduled for a sentinel node procedure using radioactive Tc-99m within 24 hours of MBI-guided biopsy\n* PART II: Patients with contraindications for core biopsy and other invasive procedures such as blood coagulation disorders, infection, or who are unwilling to discontinue use of anticoagulant medication prior to the procedure\n* PART II: Inability to provide informed consent\n* PART II: Women who have had surgery on the study breast(s) within the past 12 months",
    "miscellaneous_criteria": ""
}